Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai Rongtai Health Technology's Cyclically Adjusted PB Ratio or its related term are showing as below:
SHSE:603579'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.46 Med: 2.2 Max: 4.89
Current: 1.81
During the past years, Shanghai Rongtai Health Technology's highest Cyclically Adjusted PB Ratio was 4.89. The lowest was 1.46. And the median was 2.20.
SHSE:603579's Cyclically Adjusted PB Ratio is ranked worse than 62.96% of 602
companies
in the Travel & Leisure industry
Industry Median: 1.175
vs SHSE:603579: 1.81
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Shanghai Rongtai Health Technology's adjusted book value per share data for the three months ended in Jun. 2026 was ¥13.724. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥9.84 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Shanghai Rongtai Health Technology (SHSE:603579) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Shanghai Rongtai Health Technology Cyclically Adjusted PB Ratio Related Terms
Shanghai Rongtai Health Technology Cyclically Adjusted PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Rongtai Health Technology Cyclically Adjusted PB Ratio Chart
SHSE:603579 vs AS, HAS, LTH: Cyclically Adjusted PB Ratio Comparison
For the Leisure subindustry, Shanghai Rongtai Health Technology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Rongtai Health Technology Cyclically Adjusted PB Ratio vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai Rongtai Health Technology's Cyclically Adjusted PB Ratio falls into.
Shanghai Rongtai Health Technology Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 1.86 mean?
Shanghai Rongtai Health Technology (SHSE:603579) has a Cyclically Adjusted PB Ratio of 1.86 as of Sep. 01, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Rongtai Health Technology and its competitors. This is 15% below median its historical median of 2.20. Over the past decade, Shanghai Rongtai Health Technology's Cyclically Adjusted PB Ratio has ranged from 1.46 to 4.89. According to the industry distribution chart, Shanghai Rongtai Health Technology ranks #379 out of 602 companies in the Travel & Leisure industry, placing it in the top 63%.
Is Shanghai Rongtai Health Technology's Cyclically Adjusted PB Ratio too high?
Shanghai Rongtai Health Technology's current Cyclically Adjusted PB Ratio of 1.86 is 15% below median its 10-year median of 2.20. Over the past 10 years, this metric has ranged from a low of 1.46 to a high of 4.89. The Travel & Leisure industry median Cyclically Adjusted PB Ratio is 1.18. Shanghai Rongtai Health Technology's value of 1.86 is 58.3% above this industry median. Based on the distribution chart, Shanghai Rongtai Health Technology ranks #379 out of 602 companies in the Travel & Leisure industry, which is below the industry midpoint. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's Cyclically Adjusted PB Ratio compare to AS and HAS?
According to the Travel & Leisure industry distribution chart, Shanghai Rongtai Health Technology ranks #379 out of 602 companies for Cyclically Adjusted PB Ratio. This places Shanghai Rongtai Health Technology in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.18. Shanghai Rongtai Health Technology's value of 1.86 is 58.3% above this benchmark. Historically, Shanghai Rongtai Health Technology's own Cyclically Adjusted PB Ratio has ranged from 1.46 to 4.89 over the past decade. While the company's 10-year median is 2.20 vs. the industry median of 1.18, Shanghai Rongtai Health Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Travel & Leisure company?
The median Cyclically Adjusted PB Ratio among Travel & Leisure companies is 1.18, based on 602 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Rongtai Health Technology's current Cyclically Adjusted PB Ratio of 1.86 is 58.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Rongtai Health Technology and its competitors. For the Travel & Leisure industry, the median Cyclically Adjusted PB Ratio is 1.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Rongtai Health Technology's current Cyclically Adjusted PB Ratio is 1.86, which is 15% below median its own 10-year median of 2.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥17.51, compared to a current price of ¥18.26 — trading 4.3% above its estimated fair value. The current Cyclically Adjusted PB Ratio is 1.86, which is 15% below median its 10-year median of 2.20 and 58.3% above the Travel & Leisure industry median of 1.18. Shanghai Rongtai Health Technology's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current Cyclically Adjusted PB Ratio is 1.86 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued.
The current stock price of ¥18.26 is trading 4.3% above its estimated GF Value™ of ¥17.51.
GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.
Key valuation signals for SHSE:603579:
Cyclically Adjusted PB Ratio: 1.86 (15% below median its 10-year median of 2.20)
GF Value™: ¥17.51 vs. price of ¥18.26 (4.3% above fair value)
Industry Position: 58.3% above the Travel & Leisure median (#379 of 602)
No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
68GF Score
Get the complete analysis for SHSE:603579
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603579 has been successfully added to your 
